The authors proposed that the SAD (52) mechanism of action consists of the ability to down-regulate the expression of ABCG2 and decrease the percentage of SP cells in lung cancer cells due to the induction of ABCG2 degradation by calpain 1 activation [56]. Here, ABCG2 is linked to lung carcinoma.